The report said that over 2019-2024, the percentage of total pharmacy spending related to those drugs rose from 4 percent to 18 percentin dollar terms, from $393 million to $2.6 billion
Net result: only -5.6% from baseline at month 120 vs -17.3% at peak
The FDA advises against their use in people with a personal or family history of medullary thyroid carcinoma (MTC), in those with Multiple Endocrine Neoplasia type 2 (MEN2), or in patients with severe gastroparesis or past serious allergic reactions
Use Limitations: Not intended for human or animal consumption, therapeutic use, or diagnostic procedures
however, severe or persistent gastrointestinal symptoms may warrant dose slowing or medication adjustment
Proteins are sensitive to environmental conditions such as heat and light